Funding for Global Cancer Research and Training
The Center for Global Health (CGH) funds research to reduce the global burden of cancer and offers research training opportunities for investigators to strengthen their research abilities.
Sort the table below for current funding opportunities for global cancer research and research training.
Learn more about grants and funding from the National Institutes of Health.
Current Funding Opportunities
| Title | Announcement Number | Opening Date | Expiration Date | Additional Resources |
|---|---|---|---|---|
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) | PAR-22-085 | 5/05/2022 | 5/08/2025 | Reissue of PAR-19-193 |
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) | PAR-22-086 | 5/16/2022 | 5/08/2025 | Reissue of PAR-19-194 |
| Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) | RFA-CA-22-020 | 05/17/2022 | 08/18/2022 | |
| Notice of Special Interest (NOSI): Administrative Supplements for NCI Global Oncology Mentored Research | NOT-CA-22-036 | 03/04/2022 | 05/17/2022 |
PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
| Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research | NOT-CA-22-057 | 03/23/2022 | 05/24/2022 |
PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
| NOSI: Administrative Supplement for Global Integrative Oncology Research | NOT-CA-22-054 | 02/22/2022 | 05/15/2022 |
PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
| Notice of Special Interest (NOSI): Precision Imaging of Oral Lesions | NOT-DE-21-010 | 08/06/2021 | 09/10/2024 | |
| Mobile Health: Technology and Outcomes in Low- and Middle-Income Countries (R21/R33 - Clinical Trial Optional) | PAR-21-303 | 08/04/2021 | 12/10/2022 | |
| Notice of Special Interest (NOSI): National Cancer Institute SBIR/STTR Program Announcement Regarding Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings | NOT-CA-21-062 | 07/23/2021 | 09/07/2024 | This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program. |
| International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed | PAR-21-104 | 01/04/2021 | 03/09/2023 | |
| International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required) | PAR-21-105 | 01/04/2021 | 03/09/2023 | |
| Notice of Special Interest: Academy of Finland (AKA) – National Institutes of Health (NIH) Partnership Program | NOT-OD-21-021 | 11/13/2020 | ||
| Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments | NOT-CA-20-025 | 02/10/2020 | 05/08/2022 | Interested applicants must submit applications for this initiative using one of the following Dissemination and Implementation Research in Health FOAs:
|
| Microbial-based Cancer Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) | PAR-19-194 | 05/16/2019 | 05/08/2022 | Microbial-based Cancer Therapy - Technologies to Overcome Cancer |
| Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) | PAR-19-193 | 05/05/2019 | 05/08/2022 | Microbial-based Cancer Therapy - Technologies to Overcome Cancer |
| Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) | PAR-19-274 | 05/08/2019 | 05/08/2022 | |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | PAR-19-275 | 05/16/2019 | 05/08/2022 | |
| Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | PAR-19-276 | 05/16/2019 | 05/08/2022 |
Training Opportunities
Explore cancer research programs and research training offered and funded through CGH.